Covid-19 idiopathic pulmonary fibrosis impact largely logistical rather than clinical

Many KOLs stated that sponsors or their individual institutions mandated halting all trial activities during the worst months of the pandemic. Credit: Shutterstock.



  • Covid-19 idiopathic pulmonary fibrosis